FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Drug-Coated Peripheral Transluminal Angioplasty Catheter

PMA: P190008 · Supplement: S019 · Decision Jul 8, 2022
Classifications
1
FEI Numbers
7
Registration Numbers
7

Basic Information

Device Name
Drug-Coated Peripheral Transluminal Angioplasty Catheter
Trade Name
IN.PACT AV Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter
PMA Number
P190008
Supplement Number
S019
Device Class
FDA Class 3
Product Code
PRC
Generic Name
Drug-coated peripheral transluminal angioplasty catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
July 8, 2022
Date Received
June 28, 2022
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Additional controls be added to the luer inspection and gluing processes.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PRC Drug-Coated Peripheral Transluminal Angioplasty Catheter